A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate patient acceptance of a new MiraLax dose formulation in children currently
treated with polyethylene glycol 3350 powder for treatment of constipation.